5901 - 5950 of 8620 Results
Title
Year
- Two‐Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individuals2023OPENTitle: Two‐Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individualsJournal Name: European Journal of NeurologyPublisher: WileyVol: 30Issue #: 5Start Page: 1281End Page: 1292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.15733Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15733Citation Count: 4
-
OPENTitle: Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortiumJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 79End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2019.05.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6949373Citation Count: 69
- PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data2021OPENTitle: PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic dataJournal Name: MicrobiomePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40168-020-00993-9Best OA location URL: https://microbiomejournal.biomedcentral.com/track/pdf/10.1186/s40168-020-00993-9Citation Count: 145
- Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats2016OPENTitle: Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2016.01.020Best OA location URL: https://europepmc.org/articles/pmc4753102?pdf=renderCitation Count: 93
-
OPENTitle: Post‐traumatic Functional Mirror Movements in Klippel‐Feil SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 3Start Page: 447End Page: 449Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12405Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12405Citation Count: 1
- Alcohol improves cerebellar learning deficit in myoclonus–dystonia: A clinical and electrophysiological investigation2017RESTRICTEDTitle: Alcohol improves cerebellar learning deficit in myoclonus–dystonia: A clinical and electrophysiological investigationJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 4Start Page: 543End Page: 553Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25035Citation Count: 45
-
OPENTitle: Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2024Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2024/5580870Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1155/2024/5580870Citation Count: 0
-
RESTRICTEDTitle: Colonic inflammation in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 50Issue #:Start Page: 42End Page: 48Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.09.007Citation Count: 539
-
RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007Citation Count: 0
- Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase2017OPENTitle: Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 1Start Page: 1End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20170802Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/1/1/694077/bcj-2017-0802.pdfCitation Count: 145
- Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study2020OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 59
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 16
-
OPENTitle: SRF transcriptionally regulates the oligodendrocyte cytoskeleton during CNS myelinationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2307250121Best OA location URL: https://escholarship.org/content/qt2zh8f5zf/qt2zh8f5zf.pdfCitation Count: 4
- Graphene Microelectrode Arrays, 4D Structured Illumination Microscopy, and a Machine Learning Spike Sorting Algorithm Permit the Analysis of Ultrastructural Neuronal Changes During Neuronal Signaling in a Model of Niemann–Pick Disease Type C2024OPENTitle: Graphene Microelectrode Arrays, 4D Structured Illumination Microscopy, and a Machine Learning Spike Sorting Algorithm Permit the Analysis of Ultrastructural Neuronal Changes During Neuronal Signaling in a Model of Niemann–Pick Disease Type CJournal Name: Advanced SciencePublisher: WileyVol: 11Issue #: 44Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1002/advs.202402967Best OA location URL: https://doi.org/10.1002/advs.202402967Citation Count: 3
-
OPENTitle: Il-10 signaling reduces survival in mouse models of synucleinopathyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00169-8Best OA location URL: https://www.nature.com/articles/s41531-021-00169-8.pdfCitation Count: 12
- Comprehensive real time remote monitoring for Parkinson’s disease using Quantitative DigitoGraphy2024OPENTitle: Comprehensive real time remote monitoring for Parkinson’s disease using Quantitative DigitoGraphyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00751-wBest OA location URL: https://doi.org/10.1038/s41531-024-00751-wCitation Count: 3
- NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)2019RESTRICTEDTitle: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035Citation Count: 1
- Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson’s disease motor subtypes2018RESTRICTEDTitle: Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson’s disease motor subtypesJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 125Issue #: 6Start Page: 1007End Page: 1011Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-018-1859-3Citation Count: 10
- Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi22023OPENTitle: Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2Journal Name: CellsPublisher: MDPI AGVol: 13Issue #: 1Start Page: 53End Page: 53Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13010053Best OA location URL: https://www.mdpi.com/2073-4409/13/1/53/pdf?version=1703658023Citation Count: 0
-
RESTRICTEDTitle: CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive TrajectoriesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1138End Page: 1144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28056Citation Count: 46
-
OPENTitle: Peripheral neuropathy is associated with more frequent falls in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 54Issue #:Start Page: 46End Page: 50Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.006Best OA location URL: https://europepmc.org/articles/pmc6163065?pdf=renderCitation Count: 26
- Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease2015OPENTitle: Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's diseaseJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 93Issue #: 11Start Page: 1713End Page: 1727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.23625Citation Count: 95
- Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson’s Disease2021OPENTitle: Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2021.633655Best OA location URL: https://doi.org/10.3389/fnhum.2021.633655Citation Count: 36
- Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease2013RESTRICTEDTitle: Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 54Issue #:Start Page: 339End Page: 348Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.01.005Citation Count: 38
- The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease2020OPENTitle: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 8Start Page: 1878End Page: 1878Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9081878Best OA location URL: https://www.mdpi.com/2073-4409/9/8/1878/pdf?version=1597644425Citation Count: 6
- Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats2014OPENTitle: Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 ratsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 505End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.011Best OA location URL: https://uvadoc.uva.es/handle/10324/63882Citation Count: 47
-
OPENTitle: Normative data for subcortical regional volumes over the lifetime of the adult human brainJournal Name: NeuroImagePublisher: Elsevier BVVol: 137Issue #:Start Page: 9End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.05.016Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1053811916301355?via%3DihubCitation Count: 127
- Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications2023OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645Best OA location URL: https://doi.org/10.7554/elife.91645Citation Count: 43
-
OPENTitle: USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylationJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 3Issue #: 8Start Page: e202000768End Page: e202000768Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202000768Best OA location URL: https://www.life-science-alliance.org/content/lsa/3/8/e202000768.full.pdfCitation Count: 105
-
RESTRICTEDTitle: Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2247End Page: 2256Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29188Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9669200Citation Count: 15
-
OPENTitle: PARKIN, PINK1, and DJ1 analysis in early-onset Parkinson’s disease in IrelandJournal Name: Irish Journal of Medical Science (1971 -)Publisher: Springer Science and Business Media LLCVol: 191Issue #: 2Start Page: 901End Page: 907Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11845-021-02563-wBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9376961Citation Count: 12
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://escholarship.org/content/qt5c21d8ds/qt5c21d8ds.pdfCitation Count: 108
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/anie.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202309306Citation Count: 9
- Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity2021OPENTitle: Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicityJournal Name: RSC Chemical BiologyPublisher: Royal Society of Chemistry (RSC)Vol: 3Issue #: 1Start Page: 96End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1cb00103eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2022/cb/d1cb00103eCitation Count: 11
- Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration2010OPENTitle: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestorationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1370Issue #:Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3019295Citation Count: 41
-
OPENTitle: Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 591End Page: 601Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.03.002Best OA location URL: https://doi.org/10.1016/j.nicl.2017.03.002Citation Count: 100
-
OPENTitle: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 8Start Page: 2980End Page: 2995Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22822Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/f5e24699-93e4-49fc-a6e3-c3d92fd2d0b9Citation Count: 108
-
OPENTitle: A Bayesian mathematical model of motor and cognitive outcomes in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 6Start Page: e0178982End Page: e0178982Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0178982Best OA location URL: https://escholarship.org/content/qt09j8x8r1/qt09j8x8r1.pdfCitation Count: 15
- Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy2023OPENTitle: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106287End Page: 106287Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106287Citation Count: 9
- Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease2021OPENTitle: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2286End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092286Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2286/pdf?version=1630925823Citation Count: 13
-
OPENTitle: Chronotype, sleep, and sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105189End Page: 105189Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.10.011Citation Count: 8
-
OPENTitle: Functional Brain Networks to Evaluate Treatment Responses in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 1653End Page: 1668Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-023-01433-wBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10684458Citation Count: 1
-
OPENTitle: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 526End Page: 535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27642Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6469643Citation Count: 101
- Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)2022OPENTitle: Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)Journal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-022-06160-9Best OA location URL: https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-022-06160-9Citation Count: 7
- Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.2022OPENTitle: Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 4Start Page: 266End Page: 278Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1037/neu0000795Best OA location URL: https://psyarxiv.com/zvqge/downloadCitation Count: 5
-
RESTRICTEDTitle: Virtual Compound Screening for Discovery of Dopamine D1 Receptor Biased Allosteric ModulatorsJournal Name: Journal of Chemical Information and ModelingPublisher: American Chemical Society (ACS)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jcim.5c00972Citation Count: 0
-
OPENTitle: Lipid pathway dysfunction is prevalent in patients with Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 10Start Page: 3472End Page: 3487Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac176Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac176/45231989/awac176.pdfCitation Count: 75
-
OPENTitle: An application of generalized matrix learning vector quantization in neuroimagingJournal Name: Computer Methods and Programs in BiomedicinePublisher: Elsevier BVVol: 197Issue #:Start Page: 105708End Page: 105708Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105708Best OA location URL: https://doi.org/10.1016/j.cmpb.2020.105708Citation Count: 16
-
OPENTitle: Genetic Testing in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1384End Page: 1396Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29500Citation Count: 17
-
RESTRICTEDTitle: Validation of Fox Insight Cohort via Virtual Research Visits (4749)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4749Citation Count: 1